Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Low-cost index funds offer broad diversification with minimal fees. This guide explains how to choose funds that track wide market indexes for retirement.
26,677 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
What could turn a biotech bet into a life-changing gain? This article breaks down how to spot this millionaire-maker ...
A landmark ruling would change who pays tariff costs and could lift earnings for U.S. companies. Markets react as inv...
Two high-growth names face near-term headwinds. This guide explains why patient investors could benefit from the pull...
As July approaches, a seasoned investor lays out why Apple sits at the center of their biggest July bet, citing the S...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...
A director sold 2,700 Wingstop shares, sparking questions about the stock's outlook. This guide breaks down what insi...
Chevron’s warning on global supply outages could stall U.S. economic momentum, as higher energy costs bite households...
As markets shift in May 2026, a popular plan to generate $4,800 per year from $40,000 in dividend stocks faces realit...
AI-driven crypto projects are grabbing attention as investors seek growth beyond traditional coins. This article brea...
Rumors are swirling about meta platforms reportedly getting into prediction markets. This potential pivot could redef...
A historic 93% one-day rally in a well-known automaker set a record for the largest single-day stock gain, prompting ...